Comorbid mental disorders in substance users from a single catchment area - a clinical study

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Langås, Anne Marit ^a,d   Malt, Ulrik F ^b,c,d   Opjordsmoen, Stein ^b,c  

^a Vestre Viken Hospital Trust   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Norwegian Research Network on Mood Disorders (NORMOOD)   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ADULT; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER IDENTIFICATION TEST; ANGST HYPOMANIA CHECK LIST; ARTICLE; BIOCHEMISTRY; CATCHMENT; CHECKLIST; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DRUG USE DISORDER IDENTIFICATION TEST; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPOMANIA; INVENTORY OF DEPRESSIVE SYMPTOM; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL DISEASE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; OUTPATIENT; PREVALENCE; PSYCHIATRIC RESEARCH INTERVIEW FOR SUBSTANCE AND MENTAL DISORDER; PSYCHIATRY; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; STANLEY FOUNDATION NETWORK ENTRY QUESTIONNAIRE; STRUCTURED INTERVIEW; SUBSTANCE ABUSE; SYMPTOM CHECKLIST 90; YOUNG MANIA RATING SCALE; ADOLESCENT; CLINICAL PROTOCOL; COMPARATIVE STUDY; DRUG DEPENDENCE TREATMENT; DRUG USE; METHODOLOGY; NORWAY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RESIDENTIAL CARE; STATISTICS;

ADOLESCENT; ADULT; CATCHMENT AREA (HEALTH); CLINICAL PROTOCOLS; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG USERS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NORWAY; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; RESEARCH DESIGN; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 79751527143     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-25     Document Type: Article

References (105)

1. Albanese MJ, Clodfelter RC, Pardo TB, Ghaemi SN. Underdiagnosis of bipolar disorder in men with substance use disorder. Journal of Psychiatric Practice 2006, 12:124-127. 10.1097/00131746-200603000-00010, 16728911.
2. Ringen PA, Melle I, Birkenaes AB, Engh JA, Faerden A, Vaskinn A, Friis S, Opjordsmoen S, Andreassen OA. The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness. Acta Psychiatr Scand 2008, 118:297-304. 10.1111/j.1600-0447.2008.01244.x, 18759810.
3. Verheul R, van den BW, Hartgers C. Personality disorders predict relapse in alcoholic patients. Addict Behav 1998, 23:869-882. 10.1016/S0306-4603(98)00065-3, 9801722.
4. Torrens M, Fonseca F, Mateu G, Farre M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug & Alcohol Dependence 2005, 78:1-22. [Review] [140 refs].
5. Mazza M, Mandelli L, Di NM, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. J Affect Disord 2009, 115:27-35. 10.1016/j.jad.2008.08.019, 18845344.
6. Curran GM, Sullivan G, Williams K, Han X, Collins K, Keys J, Kotrla KJ. Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Ann Emerg Med 2003, 41:659-667. 10.1067/mem.2003.154, 12712033.
7. Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS 2005, 19(Suppl-33).
8. Cottler LB, Campbell W, Krishna VA, Cunningham-Williams RM, Abdallah AB. Predictors of high rates of suicidal ideation among drug users. Journal of Nervous & Mental Disease 2005, 193:431-437.
9. Fergusson DM, Horwood LJ, Lynskey MT. The effects of unemployment on psychiatric illness during young adulthood. Psychol Med 1997, 27:371-381. 10.1017/S0033291796004412, 9089830.
10. Caton CL, Shrout PE, Eagle PF, Opler LA, Felix A, Dominguez B. Risk factors for homelessness among schizophrenic men: a case-control study. Am J Public Health 1994, 84:265-270. 10.2105/AJPH.84.2.265, 1615013, 8296951.
11. Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2009, 66:152-161. 10.1001/archgenpsychiatry.2008.537, 19188537.
12. Goldstein BI, Levitt AJ. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disorders 2008, 10:67-78. 10.1111/j.1399-5618.2008.00461.x, 18199243.
13. Havassy BE, Alvidrez J, Owen KK. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am J Psychiatry 2004, 161:139-145. 10.1176/appi.ajp.161.1.139, 14702262.
14. Brunette MF, Mueser KT. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder. J Clin Psychiatry 2006, 67(Suppl-7). [Review] [59 refs].
15. RachBeisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv 1999, 50:1427-1434. [Review] [89 refs].
16. Moggi F, Brodbeck J, Koltzsch K, Hirsbrunner HP, Bachmann KM. One-year follow-up of dual diagnosis patients attending a 4-month integrated inpatient treatment. Eur Addict Res 2002, 8:30-37. 10.1159/000049485, 11818691.
17. Bryant KJ, Rounsaville B, Spitzer RL, Williams JB. Reliability of dual diagnosis. Substance dependence and psychiatric disorders. Journal of Nervous & Mental Disease 1992, 180:251-257.
18. Schuckit MA. Comorbidity between substance use disorders and psychiatric conditions. Addiction 2006, 101(Suppl-88). [Review] [138 refs].
19. Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 1997, 154:948-957. [see comment].
20. Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998, 18:135-174. [Review] [490 refs], 10.1016/S0893-133X(97)00113-9, 9471114.
21. Kessler RC, Amminger GP, guilar-Gaxiola S, Alonso J, Lee S, Ustun TB. Age of onset of mental disorders: a review of recent literature. Current Opinion in Psychiatry 2007, 20:359-364. [Review] [50 refs], 10.1097/YCO.0b013e32816ebc8c, 1925038, 17551351.
22. Brown SA, Inaba RK, Gillin JC, Schuckit MA, Stewart MA, Irwin MR. Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry 1995, 152:45-52.
23. Kadden RM, Kranzler HR, Rounsaville BJ. Validity of the distinction between 'substance-induced' and 'independent' depression and anxiety disorders. American Journal on Addictions 4(2)()(pp 107-117), 1995 Date of Publication: 1995 1995, 107-117.
24. Verheul R, Kranzler HR, Poling J, Tennen H, Ball S, Rounsaville BJ. Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact?. J Stud Alcohol 2000, 61:101-110.
25. Volkow ND, Fowler JS, Wang GJ. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 2002, 13:355-366. [comment]. [Review] [60 refs].
26. Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 2004, 9:557-569. [Review] [114 refs], 10.1038/sj.mp.4001507, 15098002.
27. Wise RA. Brain reward circuitry: insights from unsensed incentives. Neuron 2002, 36:229-240. [Review] [175 refs], 10.1016/S0896-6273(02)00965-0, 12383779.
28. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002, 159:1642-1652. [Review] [103 refs], 10.1176/appi.ajp.159.10.1642, 1201373, 12359667.
29. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:1403-1413. [Review] [110 refs], 10.1176/appi.ajp.162.8.1403, 16055761.
30. Brady KT, Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry 2005, 162:1483-1493. [see comment]. [Review] [119 refs], 10.1176/appi.ajp.162.8.1483, 16055769.
31. Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 2002, 59:1039-1044. 10.1001/archpsyc.59.11.1039, 12418937.
32. Volkow ND. What do we know about drug addiction?. Am J Psychiatry 2005, 162:1401-1402. 10.1176/appi.ajp.162.8.1401, 16055760.
33. Hasin DS, Grant BF. Diagnosing depressive disorders in patients with alcohol and drug problems: a comparison of the SADS-L and the DIS. J Psychiatr Res 1987, 21:301-311. 10.1016/0022-3956(87)90032-X, 3681764.
34. Hasin DS, Grant BF. Psychiatric diagnosis of patients with substance abuse problems: a comparison of two procedures, the DIS and the SADS-L. Alcoholism, drug abuse/dependence, anxiety disorders and antisocial personality disorder. J Psychiatr Res 1987, 21:7-22. 10.1016/0022-3956(87)90005-7, 3560008.
35. Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V. A validity study of the SSAGA--a comparison with the SCAN. Addiction 1999, 94:1361-1370. 10.1046/j.1360-0443.1999.94913618.x, 10615721.
36. Weiss RD, Mirin SM, Griffin ML. Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers. Br J Addict 1992, 87:179-187. [Review] [47 refs], 10.1111/j.1360-0443.1992.tb02691.x, 1554994.
37. Kranzler HR, Kadden RM, Babor TF, Tennen H, Rounsaville BJ. Validity of the SCID in substance abuse patients. Addiction 1996, 91:859-868. 10.1111/j.1360-0443.1996.tb03580.x, 8696248.
38. Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?. Compr Psychiatry 1995, 36:278-288. [erratum appears in Compr Psychiatry 1995 Sep-Oct;36(5):396], 10.1016/S0010-440X(95)90073-X, 7554872.
39. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511-2518. [see comment], 10.1001/jama.264.19.2511, 2232018.
40. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996, 66:17-31. 10.1037/h0080151, 8720638.
41. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997, 54:313-321.
42. Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry 2001, 158:1091-1098. 10.1176/appi.ajp.158.7.1091, 11431231.
43. Kringlen E, Torgersen S, Cramer V. Mental illness in a rural area: a Norwegian psychiatric epidemiological study. Social Psychiatry & Psychiatric Epidemiology 2006, 41:713-719.
44. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de GG, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, rbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA, . Investigators ESotEoMDEP Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica, Supplementum 2004, 21-27. Investigators ESotEoMDEP.
45. Currie SR, Patten SB, Williams JV, Wang J, Beck CA, el-Guebaly N, Maxwell C. Comorbidity of major depression with substance use disorders. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie 2005, 50:660-666.
46. de Graaf R, Bijl RV, Ten HM, Beekman AT, Vollebergh WA. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord 2004, 82:461-467. 10.1016/j.jad.2004.03.001, 15555699.
47. de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002, 159:620-629. 10.1176/appi.ajp.159.4.620, 11925301.
48. Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, Lewis G, Marsden J, Taylor C, Meltzer H. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001, 179:432-437. 10.1192/bjp.179.5.432, 11689401.
49. Aalto-Setala T, Marttunen M, Tuulio-Henriksson A, Poikolainen K, Lonnqvist J. One-month prevalence of depression and other DSM-IV disorders among young adults. Psychol Med 2001, 31:791-801. 10.1017/S0033291701004081, 11459377.
50. Chong MY, Chan KW, Cheng AT. Substance use disorders among adolescents in Taiwan: prevalence, sociodemographic correlates and psychiatric co-morbidity. Psychol Med 1999, 29:1387-1396. 10.1017/S0033291799001257, 10616944.
51. Pakriev S, Vasar V, Aluoja A, Shlik J. Prevalence of ICD-10 harmful use of alcohol and alcohol dependence among the rural population in Udmurtia. Alcohol & Alcoholism 1998, 33:255-264.
52. Ramsey SE, Kahler CW, Read JP, Stuart GL, Brown RA. Discriminating between substance-induced and independent depressive episodes in alcohol dependent patients. Journal of Studies on Alcohol 65(5)()(pp 672-676), 2004 Date of Publication: Sep 2004 2004, 672-676.
53. Davidson KM. Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status. Br J Psychiatry 1995, 166:199-204. 10.1192/bjp.166.2.199, 7728364.
54. Yeh HS, Lee YC, Sun HJ, Wan SR. Six months follow-up of patients with methamphetamine psychosis. Chung Hua i Hsueh Tsa Chih - Chinese Medical Journal 2001, 64:388-394.
55. Caton CL, Samet S, Hasin DS. When acute-stage psychosis and substance use co-occur: differentiating substance-induced and primary psychotic disorders. J Psychiatr Pract 2000, 6:256-266. 10.1097/00131746-200009000-00003, 15990489.
56. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry 1996, 153:1195-1201.
57. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N, Ford C, . Comorbidity of Substance Misuse and Mental Illness Collaborative study team Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003, 183:304-313. 10.1192/bjp.183.4.304, 14519608, Comorbidity of Substance Misuse and Mental Illness Collaborative study team.
58. Modestin J, Nussbaumer C, Angst K, Scheidegger P, Hell D. Use of potentially abusive psychotropic substances in psychiatric inpatients. European Archives of Psychiatry & Clinical Neuroscience 1997, 247:146-153.
59. Weaver T, Rutter D, Madden P, Ward J, Stimson G, Renton A. Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Social Psychiatry & Psychiatric Epidemiology 2001, 36:399-406.
60. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001, 48:69-82. [Review] [83 refs], 10.1016/S0920-9964(00)00114-6, 11278155.
61. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001, 3:181-188. 10.1034/j.1399-5618.2001.30403.x, 11552957.
62. Sbrana A, Bizzarri JV, Rucci P, Gonnelli C, Doria MR, Spagnolli S, Ravani L, Raimondi F, Dell'Osso L, Cassano GB. The spectrum of substance use in mood and anxiety disorders. Compr Psychiatry 2005, 46:6-13. 10.1016/j.comppsych.2004.07.017, 15714188.
63. van den Bosch LM, Verheul R, van den BW. Substance abuse in borderline personality disorder: clinical and etiological correlates. J Personal Disord 2001, 15:416-424.
64. Wolfe WL, Maisto SA. The relationship between eating disorders and substance use: moving beyond co-prevalence research. Clin Psychol Rev 2000, 20:617-631. [Review] [80 refs], 10.1016/S0272-7358(99)00009-4, 10860169.
65. Larsen TK, Melle I, Auestad B, Friis S, Haahr U, Johannessen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan TH. Substance abuse in first-episode non-affective psychosis. Schizophr Res 2006, 88:55-62. 10.1016/j.schres.2006.07.018, 16971092.
66. Helseth V, Lykke-Enger T, Johnsen J, Waal H. Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nordic Journal of Psychiatry 63(1)()(pp 72-77), 2009 Date of Publication: 2009 2009, 72-77.
67. Gråwe RWRT. Rus og psykiske lidelser i psykisk helsevern for voksne. 2006, SINTEF Helse, Ref Type: Report.
68. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007, 64:830-842. 10.1001/archpsyc.64.7.830, 17606817.
69. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991, 48:43-51.
70. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, guilar-Gaziola S, Bijl R, Borges G, Caraveo-Anduaga JJ, DeWit DJ, Kolody B, Vega WA, Wittchen HU, Kessler RC. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998, 23:893-907. 10.1016/S0306-4603(98)00076-8, 9801724.
71. Schneider U, Altmann A, Baumann M, Bernzen J, Bertz B, Bimber U, Broese T, Broocks A, Burtscheidt W, Cimander KF, Degkwitz P, Driessen M, Ehrenreich H, Fischbach E, Folkerts H, Frank H, Gurth D, Havemann-Reinecke U, Heber W, Heuer J, Hingsammer A, Jacobs S, Krampe H, Lange W, Lay T, Leimbach M, Lemke MR, Leweke M, Mangholz A, Massing W, Meyenberg R, Porzig J, Quattert T, Redner C, Ritzel G, Rollnik JD, Sauvageoll R, Schlafke D, Schmid G, Schroder H, Schwichtenberg U, Schwoon D, Seifert J, Sickelmann I, Sieveking CF, Spiess C, Stiegemann HH, Stracke R, Straetgen HD, Subkowski P, Thomasius R, Tretzel H, Verner LJ, Vitens J, Wagner T, Weirich S, Weiss I, Wendorff T, Wetterling T, Wiese B, Wittfoot J. Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first Multicentre Study in Germany. Alcohol & Alcoholism 2001, 36:219-223.
72. Hannesdottir H, Tyrfingsson T, Piha J. Psychosocial functioning and psychiatric comorbidity among substance-abusing Icelandic adolescents. Nordic Journal of Psychiatry 2001, 55:43-48. 10.1080/080394801750093742, 11827606.
73. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 2000, 176:285-289. [see comment], 10.1192/bjp.176.3.285, 10755078.
74. Adamson SJ, Todd FC, Sellman JD, Huriwai T, Porter J. Coexisting psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population. Australian & New Zealand Journal of Psychiatry 2006, 40:164-170.
75. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 1990, 147:685-695. [see comment]. [Review] [76 refs].
76. Myrick H, Brady KT. Social phobia in cocaine-dependent individuals. Am J Addict 1997, 6:99-104.
77. Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry 2001, 158:1184-1190. [Review] [69 refs], 10.1176/appi.ajp.158.8.1184, 11481147.
78. Brown SA, Schuckit MA. Changes in depression among abstinent alcoholics. J Stud Alcohol 1988, 49:412-417.
79. Verheul R. Co-morbidity of personality disorders in individuals with substance use disorders. European Psychiatry: the Journal of the Association of European Psychiatrists 2001, 16:274-282. [Review] [62 refs].
80. Rounsaville BJ, Kranzler HR, Ball S, Tennen H, Poling J, Triffleman E. Personality disorders in substance abusers: relation to substance use. Journal of Nervous & Mental Disease 1998, 186:87-95.
81. Bakken K, Landheim AS, Vaglum P. Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?. Alcohol & Alcoholism 2003, 38:54-59.
82. Conigrave KM, Hall WD, Saunders JB. The AUDIT questionnaire: choosing a cut-off score. Alcohol Use Disorder Identification Test. Addiction 1995, 90:1349-1356. 10.1111/j.1360-0443.1995.tb03552.x, 8616463.
83. Dybek I, Bischof G, Grothues J, Reinhardt S, Meyer C, Hapke U, John U, Broocks A, Hohagen F, Rumpf HJ. The reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample. J Stud Alcohol 2006, 67:473-481.
84. Selin KH. Alcohol Use Disorder Identification Test (AUDIT): what does it screen? Performance of the AUDIT against four different criteria in a Swedish population sample. Subst Use Misuse 2006, 41:1881-1899. 10.1080/10826080601025532, 17162595.
85. Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 2005, 11:22-31. 10.1159/000081413, 15608468.
86. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2001, 67:45-59. 10.1016/S0165-0327(01)00432-3, 11869752.
87. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976, 128:280-289. 10.1192/bjp.128.3.280, 1252693.
88. Haver B. Screening for psychiatric comorbidity among female alcoholics: the use of a questionnaire (SCL-90) among women early in their treatment programme. Alcohol & Alcoholism 1997, 32:725-730.
89. Benjamin AB, Mossman D, Graves NS, Sanders RD. Tests of a symptom checklist to screen for comorbid psychiatric disorders in alcoholism. Compr Psychiatry 2006, 47:227-233. 10.1016/j.comppsych.2005.08.003, 16635653.
90. Vassend O, Skrondal A. The problem of structural indeterminacy in multidimensional symptom report instruments. The case of SCL-90-R. Behaviour Research & Therapy 1999, 37:685-701.
91. Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the Global Assessment of Functioning-Split version. Compr Psychiatry 2007, 48:88-94. 10.1016/j.comppsych.2006.03.008, 17145287.
92. Vatnaland T, Vatnaland J, Friis S, Opjordsmoen S. Are GAF scores reliable in routine clinical use?. Acta Psychiatr Scand 2007, 115:326-330. 10.1111/j.1600-0447.2006.00925.x, 17355524.
93. Hasin D, Trautman K, Endicott J. Psychiatric research interview for substance and mental disorders: phenomenologically based diagnosis in patients who abuse alcohol or drugs. Psychopharmacol Bull 1998, 34:3-8.
94. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 2006, 163:689-696. 10.1176/appi.ajp.163.4.689, 16585445.
95. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1934, 59(Suppl-33). [Review] [25 refs].
96. Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D, Namia C, Novella L, Petrachi M. Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. J Personal Disord 1997, 11:279-284.
97. Corruble E, Legrand JM, Duret C, Charles G, Guelfi JD. IDS-C and IDS-sr: psychometric properties in depressed in-patients. J Affect Disord 1999, 56:95-101. 10.1016/S0165-0327(99)00055-5, 10701466.
98. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986, 18:65-87. 10.1016/0165-1781(86)90060-0, 3737788.
99. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004, 34:73-82. 10.1017/S0033291703001107, 14971628.
100. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389. 10.1192/bjp.134.4.382, 444788.
101. Zimmerman M, Chelminski I, Posternak M. A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol 2004, 19:1-7. [Review] [46 refs], 10.1097/00004850-200401000-00001, 15101563.
102. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435. 10.1192/bjp.133.5.429, 728692.
103. Favre S, Aubry JM, Gex-Fabry M, Ragama-Pardos E, McQuillan A, Bertschy G. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)]. Encephale 2003, 29:499-505. [French].
104. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, Skeppar P, Vieta E, Scott J. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord 2005, 88:217-233. 10.1016/j.jad.2005.05.011, 16125784.
105. Benazzi F. Validating Angst's "ups & downs" personality trait as a new marker of bipolar II disorder. European Archives of Psychiatry & Clinical Neuroscience 2004, 254:48-54.